ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
KSQ grabs $80M to move T-cell treatment for PD-1 resistance into the clinic
September 29, 2018KSQ is focusing on cancer at the moment, but plans to expand its CRISPRomics platform to other areas, such as immunology. -
Sanofi Genzyme partners with MSSI to support multiple sclerosis community
June 01, 2018Sanofi Genzyme, the specialty care global business unit of Sanofi, and Multiple Sclerosis Society of India (MSSI) join hands to raise awareness and to provide better treatment solutions for the 130,000 people living with multiple sclerosis (MS) in India. -
Sanofi Genzyme Announces Approval of Cerdelga by Health Canada
May 02, 2017Sanofi Genzyme, a division of Sanofi-Aventis Canada Inc., announced Health Canada has approved Cerdelga (eliglustat capsules) for the treatment of adult patients with Gaucher Disease Type 1.
Pharma Sources Insight January 2025
